Skip to content
Home - Clinical trials - Products in Development - AZD7009    
AZD7009 Ongoing studies

A number of clinical trials with AZD7009 Ongoing studies are currently in progress.

More studies will be added in due course. Additional AZD7009 Ongoing study information is available on ClinicalTrials.gov.

Study NumberStudy PhaseStart DateRecruitment Status
D1461C00006Phase II21-Sep-2005Completed
A double-blind, randomised, placebo-controlled, parallel-group, multicentre, phase II study to assess the efficacy of AZD7009 (AR H065522XX) given intravenously (infusion for 15 or 30 minutes) to patients for conversion of atrial fibrillation.


AstraZeneca websites
Search
Corporate Responsibility
Quick links - Products
Page tools
>
>
>
>